Evidence map›Paper›PMID 41095092›Full record

ArticlePlants (Basel, Switzerland)2025

Investigating the Preservation and Utilization of the Saffron (

Evanthia Dina, Antigoni Cheilari, Dimitra Karamani, Vasilis Mitsopoulos, Ioanna Diamanti, Nikolas Fokialakis, Nektarios Aligiannis

Abstract read
In one paragraph

Article in Plants (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Evanthia DinaDepartment of Pharmacognosy and Natural Products Chemistry, Faculty of Pharmacy, National and Kapodistrian University of Athens, Panepistimiopolis Zografou, 15771 Athens, Greece.
Antigoni CheilariDepartment of Pharmacognosy and Natural Products Chemistry, Faculty of Pharmacy, National and Kapodistrian University of Athens, Panepistimiopolis Zografou, 15771 Athens, Greece.ORCID 0000-0002-6180-821X
Dimitra KaramaniPellas Nature S.A., Seremes, Proastio, 58200 Edessa, Greece.
Vasilis MitsopoulosCooperative de Safran, Evripidou 1, 50010 Krokos Kozani, Greece.
Ioanna DiamantiPellas Nature S.A., Seremes, Proastio, 58200 Edessa, Greece.
Nikolas FokialakisDepartment of Pharmacognosy and Natural Products Chemistry, Faculty of Pharmacy, National and Kapodistrian University of Athens, Panepistimiopolis Zografou, 15771 Athens, Greece.ORCID 0000-0001-7028-1870
Nektarios AligiannisDepartment of Pharmacognosy and Natural Products Chemistry, Faculty of Pharmacy, National and Kapodistrian University of Athens, Panepistimiopolis Zografou, 15771 Athens, Greece.ORCID 0000-0002-3335-8135

Funding

European Council 691247
6 · The paper itself

Abstract

Medicinal and Aromatic Plant (MAP) by-products constitute a vast reservoir of bioactive metabolites with antioxidant and antimicrobial properties, offering potential for the development of high added value natural products. This study focuses on the by-product (tepals) remaining during the process of receiving the stigma of

Indexed as

adsorption resinCrocus sativus by-productsmicrowave assisted extractionpilot scalesaffrontepals

Identifiers

PMID41095092
PMCPMC12526476

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.